9-cyclopropyl-6,7-difluoro-3-hydroxyl-8-methoxy-4-oxo-4,9-dihydrothieno[2,3-b]quinoline-2-carboxamide | 1247951-91-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 9-cyclopropyl-6,7-difluoro-3-hydroxyl-8-methoxy-4-oxo-4,9-dihydrothieno[2,3-b]quinoline-2-carboxamide
• 英文别名: 9-cyclopropyl-6,7-difluoro-3-hydroxy-8-methoxy-4-oxothieno[2,3-b]quinoline-2-carboxamide
• CAS: 1247951-91-2
• 化学式: C₁₆H₁₂F₂N₂O₄S
• 分子量: 366.345
• InChiKey: GOMCPWYLAWIAQV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  121
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  1-((R)-methyl-1-pyrrolidin-3-yl)-ethylamine 、 9-cyclopropyl-6,7-difluoro-3-hydroxyl-8-methoxy-4-oxo-4,9-dihydrothieno[2,3-b]quinoline-2-carboxamide 在 吡啶 、 盐酸 作用下， 以 甲醇 为溶剂， 反应 24.0h， 以29%的产率得到(R)-7-(3-(2-aminopropan-2-yl)pyrrolidin-1-yl)-9-cyclopropyl-6-fluoro-3-hydroxyl-8-methoxy-4-oxo-4,9-dihydrothieno[2,3-b]quinoline-2-carboxamide hydrochloride
  参考文献：
  名称：

  HYDROXYTHIENOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS

  摘要：

  本文披露了羟基噻唑喹啉和相关化合物及其药学上可接受的盐，可用作抗病毒剂，并具有以下通用式的R2、R6和R7变量的定义。本文提供的某些化合物具有强大的抗菌、抗原虫或抗真菌活性，并特别适用于治疗MRSA感染。本发明还提供了制药组合物、含有羟基噻唑喹啉与一种或多种其他活性剂的制药组合物，以及通过向患有微生物感染的动物投予有效量的羟基噻唑喹啉或相关化合物来治疗动物的微生物感染的方法。

  公开号：

  US20100256112A1

文献信息

• Hydroxylthienoquinolones and related compounds as anti-infective agents
  申请人：Achillion Pharmaceuticals, Inc.

  公开号：US08173636B2

  公开（公告）日：2012-05-08

  Disclosed herein are hydroxylthienoquinolones and related compounds and their pharmaceutically acceptable salts useful as antiviral agents and having the general formula in which the variables R2, R6, and R7 are defined herein. Certain compounds provided herein possess potent antibacterial, antiprotozoal, or antifungal activity and are particularly efficacious for the treatment of MRSA infections. The invention also provides pharmaceutical compositions, pharmaceutical compositions containing a hydroxylthienoquinolone in combination with one or more other active agent, and methods of treating microbial infections in animals by administering an effective amount of a hydroxylthienoquinolone or related compound to an animal suffering from a microbial infection.

  本文公开了羟基噻唑喹啉和相关化合物及其药学上可接受的盐，用作抗病毒剂，并具有以下通式： 其中变量R2、R6和R7在此定义。本文提供的某些化合物具有强效的抗菌、抗原虫或抗真菌活性，并且在治疗MRSA感染方面特别有效。本发明还提供了制药组合物、含有羟基噻唑喹啉与一种或多种其他活性剂的制药组合物，以及通过向患有微生物感染的动物投与有效量的羟基噻唑喹啉或相关化合物来治疗动物微生物感染的方法。
• US8173636B2
  申请人：——

  公开号：US8173636B2

  公开（公告）日：2012-05-08
• [EN] HYDROXYTHIENOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS<br/>[FR] HYDROXYLTHIÉNOQUINOLONES ET COMPOSÉS APPARENTÉS UTILISABLES EN TANT QU'AGENTS ANTI-INFECTIEUX
  申请人：ACHILLION PHARMACEUTICALS INC

  公开号：WO2010115184A2

  公开（公告）日：2010-10-07

  Disclosed herein are hydroxythienoquinolones and related compounds and their pharmaceutically acceptable salts useful as antiviral agents and having the general formula (I) in which the variables R2, R6, and R7 are defined herein. Certain compounds provided herein possess potent antibacterial, antiprotozoal, or antifungal activity and are particularly efficacious for the treatment of MRSA infections. The invention also provides pharmaceutical compositions, pharmaceutical compositions containing a hydroxythienoquinolone in combination with one or more other active agent, and methods of treating microbial infections in animals by administering an effective amount of a hydroxythienoquinolone or related compound to an animal suffering from a microbial infection.